Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	G protein-coupled receptor activity	OR7D4 OR5M9 GPR65 FZD3 OR5AU1 GPR34 AVPR2 OR5D14 CCR9 GABBR2 GRM5 F2R LGR5 FZD8 ADORA2B LPAR6 OR7D2 APLNR OR52N4 SCTR OR6C6	1.83e-08	884	112	21	GO:0004930
GeneOntologyMolecularFunction	transmembrane signaling receptor activity	GABRB2 GABRB3 OR7D4 OR5M9 GPR65 FZD3 OR5AU1 GPR34 AVPR2 OR5D14 CCR9 GABBR2 GRM5 F2R LGR5 FZD8 ADORA2B LPAR6 OR7D2 APLNR OR52N4 SCTR OR6C6 MUSK	3.78e-07	1353	112	24	GO:0004888
GeneOntologyMolecularFunction	alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity	MGAT4B MGAT4A	9.32e-05	3	112	2	GO:0008454
GeneOntologyMolecularFunction	GABA receptor activity	GABRB2 GABRB3 GABBR2	2.45e-04	22	112	3	GO:0016917
GeneOntologyMolecularFunction	transporter activity	GABRB2 GABRB3 CACNA1A CACNA1E ATP13A4 ABCC11 NIPAL3 CIDEA SLC32A1 PIEZO2 SLC22A8 NALCN SLC25A2 SCN10A OSCP1 SLC16A7 CNGB1	8.28e-04	1289	112	17	GO:0005215
GeneOntologyMolecularFunction	transmembrane transporter activity	GABRB2 GABRB3 CACNA1A CACNA1E ATP13A4 ABCC11 NIPAL3 SLC32A1 PIEZO2 SLC22A8 NALCN SLC25A2 SCN10A OSCP1 SLC16A7 CNGB1	8.91e-04	1180	112	16	GO:0022857
GeneOntologyMolecularFunction	Wnt-protein binding	FZD3 FZD8 MUSK	9.06e-04	34	112	3	GO:0017147
GeneOntologyMolecularFunction	G protein-coupled peptide receptor activity	AVPR2 F2R LGR5 APLNR SCTR	9.23e-04	133	112	5	GO:0008528
GeneOntologyMolecularFunction	voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels	CACNA1A CACNA1E	1.09e-03	9	112	2	GO:0099511
GeneOntologyMolecularFunction	voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels	CACNA1A CACNA1E	1.09e-03	9	112	2	GO:0099626
GeneOntologyMolecularFunction	inorganic molecular entity transmembrane transporter activity	GABRB2 GABRB3 CACNA1A CACNA1E ATP13A4 ABCC11 NIPAL3 SLC32A1 SLC22A8 NALCN SCN10A CNGB1	1.12e-03	758	112	12	GO:0015318
GeneOntologyMolecularFunction	peptide receptor activity	AVPR2 F2R LGR5 APLNR SCTR	1.16e-03	140	112	5	GO:0001653
GeneOntologyBiologicalProcess	G protein-coupled receptor signaling pathway	OR7D4 OR5M9 GPR65 FZD3 OR5AU1 GPR34 AVPR2 TCP11 OR5D14 CCR9 GABBR2 GRM5 WNK1 F2R LGR5 FZD8 ADORA2B LPAR6 PLCH2 OR7D2 APLNR OR52N4 SCTR GNA15 C5 OR6C6 CNGB1	4.82e-09	1395	112	27	GO:0007186
GeneOntologyBiologicalProcess	positive regulation of small GTPase mediated signal transduction	RELN GPR65 F2R ITPKB LPAR6 MUSK	1.09e-05	92	112	6	GO:0051057
GeneOntologyBiologicalProcess	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	GPR65 AVPR2 TCP11 GABBR2 GRM5 LGR5 ADORA2B SCTR GNA15	2.64e-05	286	112	9	GO:0007188
GeneOntologyBiologicalProcess	gamma-aminobutyric acid signaling pathway	GABRB2 GABRB3 CACNA1A GABBR2	3.79e-05	35	112	4	GO:0007214
GeneOntologyBiologicalProcess	synaptic transmission, GABAergic	GABRB2 GABRB3 CACNA1A GABBR2 NALCN	5.16e-05	74	112	5	GO:0051932
GeneOntologyBiologicalProcess	synaptic signaling	GABRB2 GABRB3 CACNA1A CACNA1E RELN GABBR2 GRM5 WNK1 F2R SLC32A1 ADORA2B MCTP1 NALCN SCTR GNA15 MUSK	7.44e-05	976	112	16	GO:0099536
GeneOntologyBiologicalProcess	phospholipase C-activating G protein-coupled receptor signaling pathway	GPR65 GRM5 F2R LPAR6 PLCH2 GNA15	8.78e-05	133	112	6	GO:0007200
GeneOntologyBiologicalProcess	regulation of synaptic transmission, cholinergic	CACNA1A NALCN MUSK	1.00e-04	17	112	3	GO:0032222
GeneOntologyBiologicalProcess	monoatomic ion transmembrane transport	GABRB2 GABRB3 CACNA1A CACNA1E ATP13A4 RELN ABCC11 NIPAL3 WNK1 F2R SLC32A1 PIEZO2 NALCN PLCH2 APLNR SCN10A CNGB1	1.06e-04	1115	112	17	GO:0034220
GeneOntologyBiologicalProcess	monoatomic ion transport	GABRB2 GABRB3 CACNA1A CACNA1E ATP13A4 RELN ABCC11 NIPAL3 WNK1 F2R SLC32A1 PIEZO2 SLC22A8 NALCN PLCH2 APLNR SCN10A NKAIN3 CNGB1	1.44e-04	1374	112	19	GO:0006811
GeneOntologyBiologicalProcess	anterograde trans-synaptic signaling	GABRB2 GABRB3 CACNA1A CACNA1E RELN GABBR2 GRM5 WNK1 F2R SLC32A1 ADORA2B MCTP1 NALCN SCTR MUSK	1.54e-04	931	112	15	GO:0098916
GeneOntologyBiologicalProcess	chemical synaptic transmission	GABRB2 GABRB3 CACNA1A CACNA1E RELN GABBR2 GRM5 WNK1 F2R SLC32A1 ADORA2B MCTP1 NALCN SCTR MUSK	1.54e-04	931	112	15	GO:0007268
GeneOntologyBiologicalProcess	trans-synaptic signaling	GABRB2 GABRB3 CACNA1A CACNA1E RELN GABBR2 GRM5 WNK1 F2R SLC32A1 ADORA2B MCTP1 NALCN SCTR MUSK	1.69e-04	939	112	15	GO:0099537
GeneOntologyBiologicalProcess	response to pain	CACNA1A CACNA1E RELN SCN10A	1.69e-04	51	112	4	GO:0048265
GeneOntologyBiologicalProcess	meiotic sister chromatid cohesion, centromeric	BUB1 BUB1B	2.89e-04	5	112	2	GO:0051754
GeneOntologyBiologicalProcess	regulation of adenylate cyclase activity	AVPR2 GABBR2 LGR5 ADORA2B	2.98e-04	59	112	4	GO:0045761
GeneOntologyCellularComponent	synaptic membrane	GABRB2 GABRB3 CACNA1A CACNA1E FZD3 GABBR2 CSMD2 GRM5 F2R AP2M1 SCN10A SLC16A7 MUSK	1.47e-05	583	112	13	GO:0097060
GeneOntologyCellularComponent	postsynaptic membrane	GABRB2 GABRB3 CACNA1A CACNA1E GABBR2 CSMD2 GRM5 F2R SLC16A7 MUSK	6.52e-05	405	112	10	GO:0045211
GeneOntologyCellularComponent	GABA receptor complex	GABRB2 GABRB3 GABBR2	1.86e-04	21	112	3	GO:1902710
GeneOntologyCellularComponent	GABA-ergic synapse	GABRB2 GABRB3 CACNA1E GABBR2 WNK1 SLC32A1	2.56e-04	164	112	6	GO:0098982
GeneOntologyCellularComponent	Mon1-Ccz1 complex	CCZ1B CCZ1	2.82e-04	5	112	2	GO:0035658
GeneOntologyCellularComponent	presynaptic membrane	GABRB2 CACNA1A CACNA1E FZD3 GABBR2 AP2M1 SCN10A	7.37e-04	277	112	7	GO:0042734
HumanPheno	Abnormality of central nervous system electrophysiology	GABRB2 GABRB3 CACNA1A CACNA1E RELN B4GAT1 UBAP1 MORC2 GABBR2 SLC32A1 TMEM106B AP2M1 PIEZO2 NALCN BUB1 BUB1B MUSK	5.46e-07	738	33	17	HP:0030178
HumanPheno	Abnormal nervous system electrophysiology	GABRB2 GABRB3 CACNA1A CACNA1E RELN B4GAT1 UBAP1 MORC2 GABBR2 WNK1 SLC32A1 TMEM106B AP2M1 PIEZO2 NALCN BUB1 BUB1B MUSK	2.56e-06	924	33	18	HP:0001311
HumanPheno	Generalized myoclonic seizure	GABRB3 CACNA1A MBOAT7 GABBR2 SLC32A1 AP2M1 BUB1B	3.43e-05	148	33	7	HP:0002123
HumanPheno	Absent palmar crease	PIEZO2 NALCN MUSK	6.78e-05	13	33	3	HP:0010489
HumanPheno	Generalized-onset motor seizure	GABRB3 CACNA1A RELN MBOAT7 GABBR2 SLC32A1 AP2M1 BUB1B	7.48e-05	228	33	8	HP:0032677
HumanPheno	EEG with focal epileptiform discharges	GABRB3 CACNA1A RELN GABBR2 SLC32A1 AP2M1	9.03e-05	118	33	6	HP:0011185
HumanPheno	Epileptic encephalopathy	GABRB2 GABRB3 CACNA1A CACNA1E GABBR2 AP2M1	9.47e-05	119	33	6	HP:0200134
HumanPheno	Aplasia/Hypoplasia of the palmar creases	PIEZO2 NALCN MUSK	1.58e-04	17	33	3	HP:0010488
HumanPheno	Atypical absence seizure	GABRB3 CACNA1A SLC32A1 AP2M1	1.97e-04	46	33	4	HP:0007270
HumanPheno	Dyskinesia	GABRB2 GABRB3 CACNA1A GABBR2 SLC32A1 NALCN PGAP1	2.18e-04	198	33	7	HP:0100660
HumanPheno	EEG with abnormally slow frequencies	GABRB2 CACNA1A GABBR2 TMEM106B AP2M1	2.22e-04	88	33	5	HP:0011203
MousePheno	abnormal inhibitory postsynaptic potential	GABRB3 GABBR2 SLC32A1	9.17e-06	8	78	3	MP:0002911
Domain	GPCR_Rhodpsn_7TM	OR7D4 OR5M9 GPR65 OR5AU1 GPR34 AVPR2 OR5D14 CCR9 F2R LGR5 ADORA2B LPAR6 OR7D2 APLNR OR52N4 OR6C6	1.91e-06	670	110	16	IPR017452
Domain	7tm_1	OR7D4 OR5M9 GPR65 OR5AU1 GPR34 AVPR2 OR5D14 CCR9 F2R LGR5 ADORA2B LPAR6 OR7D2 APLNR OR52N4 OR6C6	2.18e-06	677	110	16	PF00001
Domain	G_PROTEIN_RECEP_F1_1	OR7D4 OR5M9 GPR65 OR5AU1 GPR34 AVPR2 OR5D14 CCR9 F2R LGR5 ADORA2B LPAR6 OR7D2 APLNR OR52N4 OR6C6	2.54e-06	685	110	16	PS00237
Domain	G_PROTEIN_RECEP_F1_2	OR7D4 OR5M9 GPR65 OR5AU1 GPR34 AVPR2 OR5D14 CCR9 F2R LGR5 ADORA2B LPAR6 OR7D2 APLNR OR52N4 OR6C6	2.84e-06	691	110	16	PS50262
Domain	GPCR_Rhodpsn	OR7D4 OR5M9 GPR65 OR5AU1 GPR34 AVPR2 OR5D14 CCR9 F2R LGR5 ADORA2B LPAR6 OR7D2 APLNR OR52N4 OR6C6	2.89e-06	692	110	16	IPR000276
Domain	MARCH-like	MARCHF9 MARCHF11 MARCHF4	1.09e-05	8	110	3	IPR033275
Domain	RINGv	MARCHF9 MARCHF11 MARCHF4	3.17e-05	11	110	3	PF12906
Domain	ZF_RING_CH	MARCHF9 MARCHF11 MARCHF4	3.17e-05	11	110	3	PS51292
Domain	DUF1712	CCZ1B CCZ1	3.44e-05	2	110	2	PF08217
Domain	Mad3_BUB1_I	BUB1 BUB1B	3.44e-05	2	110	2	PF08311
Domain	Mad3_BUB1_I	BUB1 BUB1B	3.44e-05	2	110	2	SM00777
Domain	BUB1_N	BUB1 BUB1B	3.44e-05	2	110	2	PS51489
Domain	DUF1712_fun	CCZ1B CCZ1	3.44e-05	2	110	2	IPR013176
Domain	Bub1/Mad3	BUB1 BUB1B	3.44e-05	2	110	2	IPR015661
Domain	Mad3/Bub1_I	BUB1 BUB1B	3.44e-05	2	110	2	IPR013212
Domain	GABAAb_rcpt	GABRB2 GABRB3	1.03e-04	3	110	2	IPR002289
Domain	Znf_RING-CH	MARCHF9 MARCHF11 MARCHF4	1.27e-04	17	110	3	IPR011016
Domain	RINGv	MARCHF9 MARCHF11 MARCHF4	1.27e-04	17	110	3	SM00744
Domain	Glyco_transf_54	MGAT4B MGAT4A	2.05e-04	4	110	2	PF04666
Domain	Glyco_transf_54	MGAT4B MGAT4A	2.05e-04	4	110	2	IPR006759
Domain	-	FZD3 FZD8 MUSK	2.45e-04	21	110	3	1.10.2000.10
Domain	Channel_four-helix_dom	CACNA1A CACNA1E NALCN SCN10A	3.54e-04	57	110	4	IPR027359
Domain	-	CACNA1A CACNA1E NALCN SCN10A	3.54e-04	57	110	4	1.20.120.350
Domain	Frizzled_dom	FZD3 FZD8 MUSK	3.68e-04	24	110	3	IPR020067
Domain	FZ	FZD3 FZD8 MUSK	3.68e-04	24	110	3	PS50038
Domain	Fz	FZD3 FZD8 MUSK	3.68e-04	24	110	3	PF01392
Domain	Ion_trans_dom	CACNA1A CACNA1E NALCN SCN10A CNGB1	5.70e-04	114	110	5	IPR005821
Domain	Ion_trans	CACNA1A CACNA1E NALCN SCN10A CNGB1	5.70e-04	114	110	5	PF00520
Domain	VDCC_a1su_IQ	CACNA1A CACNA1E	7.08e-04	7	110	2	IPR014873
Domain	GPHH	CACNA1A CACNA1E	7.08e-04	7	110	2	PF16905
Domain	GPHH_dom	CACNA1A CACNA1E	7.08e-04	7	110	2	IPR031649
Domain	Ca_chan_IQ	CACNA1A CACNA1E	7.08e-04	7	110	2	SM01062
Domain	Ca_chan_IQ	CACNA1A CACNA1E	7.08e-04	7	110	2	PF08763
Domain	VDCCAlpha1	CACNA1A CACNA1E	1.50e-03	10	110	2	IPR002077
Domain	Frizzled	FZD3 FZD8	1.83e-03	11	110	2	IPR000539
Domain	Frizzled	FZD3 FZD8	1.83e-03	11	110	2	PF01534
Domain	Frizzled	FZD3 FZD8	1.83e-03	11	110	2	SM01330
Domain	GPCR_3_CS	GABBR2 GRM5	2.99e-03	14	110	2	IPR017979
Domain	Frizzled/SFRP	FZD3 FZD8	3.91e-03	16	110	2	IPR015526
Domain	GPCR_2_secretin-like	FZD3 FZD8 SCTR	5.33e-03	60	110	3	IPR000832
Domain	GPCR_2-like	FZD3 FZD8 SCTR	5.33e-03	60	110	3	IPR017981
Domain	G_PROTEIN_RECEP_F2_4	FZD3 FZD8 SCTR	5.58e-03	61	110	3	PS50261
Domain	FRI	FZD3 FZD8	6.09e-03	20	110	2	SM00063
Pathway	WP_GPCRS_NONODORANT	GPR65 FZD3 AVPR2 CCR9 GABBR2 GRM5 F2R FZD8 ADORA2B LPAR6 APLNR SCTR	7.04e-08	266	86	12	MM15843
Pathway	WP_GABA_RECEPTOR_SIGNALING	GABRB2 GABRB3 GABBR2 SLC32A1 AP2M1	1.13e-06	31	86	5	M39369
Pathway	REACTOME_GPCR_LIGAND_BINDING	GPR65 FZD3 AVPR2 CCR9 GABBR2 GRM5 F2R FZD8 ADORA2B LPAR6 APLNR SCTR C5	4.28e-06	463	86	13	M507
Pathway	KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	GABRB2 GABRB3 AVPR2 GABBR2 GRM5 F2R ADORA2B LPAR6 APLNR SCTR	5.91e-06	272	86	10	M13380
Pathway	REACTOME_SIGNALING_BY_GPCR	GPR65 FZD3 AVPR2 CCR9 GABBR2 GRM5 F2R FZD8 ADORA2B LPAR6 APLNR SCTR GNA15 C5 VAV2	1.99e-05	702	86	15	M746
Pathway	REACTOME_GPCR_LIGAND_BINDING	GPR65 AVPR2 CCR9 GABBR2 GRM5 F2R ADORA2B LPAR6 APLNR SCTR C5	5.84e-05	430	86	11	MM15160
Pathway	REACTOME_MATURATION_OF_SPIKE_PROTEIN	MGAT4B MGAT4A STT3A ST6GALNAC4	7.31e-05	37	86	4	M41728
Pathway	KEGG_CALCIUM_SIGNALING_PATHWAY	CACNA1A CACNA1E GRM5 F2R ITPKB ADORA2B GNA15	1.06e-04	178	86	7	M2890
Pathway	REACTOME_SIGNALING_BY_GPCR	GPR65 AVPR2 CCR9 GABBR2 GRM5 F2R ADORA2B LPAR6 APLNR SCTR GNA15 C5 VAV2	1.39e-04	646	86	13	MM14962
Pathway	WP_GPCRS_CLASS_A_RHODOPSINLIKE	GPR65 GPR34 AVPR2 CCR9 F2R ADORA2B APLNR	1.39e-04	186	86	7	MM15994
Pathway	WP_GPCRS_CLASS_A_RHODOPSINLIKE	GPR65 GPR34 AVPR2 CCR9 F2R ADORA2B LPAR6 APLNR	1.84e-04	260	86	8	M39397
Pathway	KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_LGR_RSPO	FZD3 LGR5 FZD8	1.98e-04	19	86	3	M47833
Pathway	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES	GABRB2 GABRB3 CACNA1A CACNA1E GABBR2 SLC32A1 AP2M1	3.01e-04	211	86	7	MM14502
Pathway	REACTOME_TRANSLATION_OF_SARS_COV_2_STRUCTURAL_PROTEINS	MGAT4B MGAT4A STT3A ST6GALNAC4	3.99e-04	57	86	4	M41730
Pathway	REACTOME_LATE_SARS_COV_2_INFECTION_EVENTS	MGAT4B MGAT4A STT3A ST6GALNAC4	8.71e-04	70	86	4	M46438
Pathway	REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS	GPR65 AVPR2 CCR9 F2R ADORA2B LPAR6 APLNR C5	9.00e-04	330	86	8	M18334
Pathway	REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS	GPR65 AVPR2 CCR9 F2R ADORA2B LPAR6 APLNR C5	9.54e-04	333	86	8	MM14963
Pathway	REACTOME_NEURONAL_SYSTEM	GABRB2 GABRB3 CACNA1A CACNA1E GABBR2 GRM5 SLC32A1 AP2M1	9.92e-04	335	86	8	MM14503
Pathway	WP_DRAVET_SYNDROME_SCN1AA1783V_POINT_MUTATION_MODEL	GABRB3 CACNA1A GABBR2 SLC16A7	1.02e-03	73	86	4	MM16641
Pubmed	GABA neurotransmitter signaling in the developing mouse lens: dynamic regulation of components and functionality.	GABRB2 GABRB3 GABBR2 SLC32A1	3.23e-07	18	114	4	18985723
Pubmed	Reviews in molecular biology and biotechnology: transmembrane signaling by G protein-coupled receptors.	AVPR2 CCR9 ADORA2B LPAR6 APLNR SCTR GNA15 C5	3.40e-07	200	114	8	18240029
Pubmed	Mechanoreceptor signal convergence and transformation in the dorsal horn flexibly shape a diversity of outputs to the brain.	GABRB3 SLC32A1 PIEZO2 SCN10A	5.09e-07	20	114	4	36334588
Pubmed	Migration defects of cdk5(-/-) neurons in the developing cerebellum is cell autonomous.	GABRB2 GABRB3 RELN	6.81e-07	6	114	3	10407039
Pubmed	Signaling Modification by GPCR Heteromer and Its Implication on X-Linked Nephrogenic Diabetes Insipidus.	AVPR2 SCTR	1.07e-05	2	114	2	27649563
Pubmed	β-cell proliferation is associated with increased A-type γ-aminobutyric acid receptor expression in pancreatectomized mice.	GABRB2 GABRB3	1.07e-05	2	114	2	23486367
Pubmed	Compensatory contribution of Cav2.3 channels to acetylcholine release at the neuromuscular junction of tottering mice.	CACNA1A CACNA1E	1.07e-05	2	114	2	16381801
Pubmed	Physiological and glycomic characterization of N-acetylglucosaminyltransferase-IVa and -IVb double deficient mice.	MGAT4B MGAT4A	1.07e-05	2	114	2	20015870
Pubmed	Kinetochore localisation and phosphorylation of the mitotic checkpoint components Bub1 and BubR1 are differentially regulated by spindle events in human cells.	BUB1 BUB1B	1.07e-05	2	114	2	11792804
Pubmed	Kinetic properties and substrate specificities of two recombinant human N-acetylglucosaminyltransferase-IV isozymes.	MGAT4B MGAT4A	1.07e-05	2	114	2	17006639
Pubmed	Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival.	BUB1 BUB1B	1.07e-05	2	114	2	11782350
Pubmed	BubR1 recruitment to the kinetochore via Bub1 enhances spindle assembly checkpoint signaling.	BUB1 BUB1B	1.07e-05	2	114	2	35767360
Pubmed	Estrous cycle variations in GABA(A) receptor phosphorylation enable rapid modulation by anabolic androgenic steroids in the medial preoptic area.	GABRB2 GABRB3	1.07e-05	2	114	2	22989919
Pubmed	The mouse mitotic checkpoint gene bub1b, a novel bub1 family member, is expressed in a cell cycle-dependent manner.	BUB1 BUB1B	1.07e-05	2	114	2	9889005
Pubmed	Mutations of mitotic checkpoint genes in human cancers.	BUB1 BUB1B	1.07e-05	2	114	2	9521327
Pubmed	Correlation of BUB1 and BUB1B with the development and prognosis of endometrial cancer.	BUB1 BUB1B	1.07e-05	2	114	2	39048649
Pubmed	Aberrant expression of N-acetylglucosaminyltransferase-IVa and IVb (GnT-IVa and b) in pancreatic cancer.	MGAT4B MGAT4A	1.07e-05	2	114	2	16434023
Pubmed	BUB1 and BUBR1 inhibition decreases proliferation and colony formation, and enhances radiation sensitivity in pediatric glioblastoma cells.	BUB1 BUB1B	1.07e-05	2	114	2	23728478
Pubmed	Sedation and anesthesia mediated by distinct GABA(A) receptor isoforms.	GABRB2 GABRB3	1.07e-05	2	114	2	13679430
Pubmed	Increased expression of GABA(A) receptor beta-subunits in the hippocampus of patients with temporal lobe epilepsy.	GABRB2 GABRB3	1.07e-05	2	114	2	14503638
Pubmed	Loss of Centromere Cohesion in Aneuploid Human Oocytes Correlates with Decreased Kinetochore Localization of the Sac Proteins Bub1 and Bubr1.	BUB1 BUB1B	1.07e-05	2	114	2	28287092
Pubmed	A molecular basis for the differential roles of Bub1 and BubR1 in the spindle assembly checkpoint.	BUB1 BUB1B	1.07e-05	2	114	2	25611342
Pubmed	Direct binding of GABAA receptor β2 and β3 subunits to gephyrin.	GABRB2 GABRB3	1.07e-05	2	114	2	23205938
Pubmed	Immunocytochemical localization of the GABAB2 receptor subunit in the glomeruli of the mouse main olfactory bulb.	GABRB2 GABBR2	1.07e-05	2	114	2	16714082
Pubmed	Defects During Mecp2 Null Embryonic Cortex Development Precede the Onset of Overt Neurological Symptoms.	CACNA1A RELN GRM5 SLC32A1	1.47e-05	45	114	4	25979088
Pubmed	The spindle assembly checkpoint is not essential for CSF arrest of mouse oocytes.	BUB1 BUB1B	3.19e-05	3	114	2	15611331
Pubmed	Transgenic overexpression of furin increases epileptic susceptibility.	GABRB2 GABRB3	3.19e-05	3	114	2	30333479
Pubmed	Hippocampal dysregulation of FMRP/mGluR5 signaling in engrailed-2 knockout mice: a model of autism spectrum disorders.	GABRB3 GRM5	3.19e-05	3	114	2	26559723
Pubmed	BubR1 Promotes Bub3-Dependent APC/C Inhibition during Spindle Assembly Checkpoint Signaling.	BUB1 BUB1B	3.19e-05	3	114	2	28943088
Pubmed	Protrudin modulates seizure activity through GABAA receptor regulation.	GABRB2 GABRB3	3.19e-05	3	114	2	31772151
Pubmed	Reelin signaling modulates GABAB receptor function in the neocortex.	RELN GABBR2	3.19e-05	3	114	2	32083308
Pubmed	BUBs Are New Biomarkers of Promoting Tumorigenesis and Affecting Prognosis in Breast Cancer.	BUB1 BUB1B	3.19e-05	3	114	2	35493295
Pubmed	PI3KC3 complex subunit NRBF2 is required for apoptotic cell clearance to restrict intestinal inflammation.	CCZ1B CCZ1	3.19e-05	3	114	2	32160108
Pubmed	Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia.	GABRB3 SLC32A1	3.19e-05	3	114	2	17471287
Pubmed	The hBUB1 and hBUBR1 kinases sequentially assemble onto kinetochores during prophase with hBUBR1 concentrating at the kinetochore plates in mitosis.	BUB1 BUB1B	3.19e-05	3	114	2	9914370
Pubmed	Characterization of the tetratricopeptide-containing domain of BUB1, BUBR1, and PP5 proves that domain amphiphilicity over amino acid sequence specificity governs protein adsorption and interfacial activity.	BUB1 BUB1B	3.19e-05	3	114	2	18547097
Pubmed	Effects of thyrotropin releasing hormone on cerebellar mutant mice--a kinesiological comparison between rolling mouse Nagoya, weaver and reeler.	CACNA1A RELN	3.19e-05	3	114	2	6811784
Pubmed	Expression and prognosis analyses of BUB1, BUB1B and BUB3 in human sarcoma.	BUB1 BUB1B	3.19e-05	3	114	2	33872216
Pubmed	A novel germ cell protein, SPIF (sperm PKA interacting factor), is essential for the formation of a PKA/TCP11 complex that undergoes conformational and phosphorylation changes upon capacitation.	TCP11 MROH2B	3.19e-05	3	114	2	27105888
Pubmed	Structural analysis reveals features of the spindle checkpoint kinase Bub1-kinetochore subunit Knl1 interaction.	BUB1 BUB1B	3.19e-05	3	114	2	22331848
Pubmed	Piezo2 expressing nociceptors mediate mechanical sensitization in experimental osteoarthritis.	PIEZO2 SCN10A	3.19e-05	3	114	2	37120427
Pubmed	Impaired phosphorylation and mis-localization of Bub1 and BubR1 are responsible for the defective mitotic checkpoint function in Brca2-mutant thymic lymphomas.	BUB1 BUB1B	3.19e-05	3	114	2	14646599
Pubmed	The intracellular C-terminus confers compartment-specific targeting of voltage-gated calcium channels.	CACNA1A CACNA1E	3.19e-05	3	114	2	38996073
Pubmed	Loss of APC induces polyploidy as a result of a combination of defects in mitosis and apoptosis.	BUB1 BUB1B	3.19e-05	3	114	2	17227893
Pubmed	Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics.	CACNA1A CACNA1E	3.19e-05	3	114	2	24523520
Pubmed	GABAA receptor beta 1, beta 2, and beta 3 subunits: comparisons in DBA/2J and C57BL/6J mice.	GABRB2 GABRB3	3.19e-05	3	114	2	7893750
Pubmed	Expression and distribution of GABAA receptor subtypes in human alcoholic cerebral cortex.	GABRB2 GABRB3	3.19e-05	3	114	2	11085308
Pubmed	GABAA receptor beta subunit mRNA expression in the human alcoholic brain.	GABRB2 GABRB3	3.19e-05	3	114	2	15337300
Pubmed	Differential expression of GABAA/benzodiazepine receptor beta 1, beta 2, and beta 3 subunit mRNAs in the developing mouse cerebellum.	GABRB2 GABRB3	3.19e-05	3	114	2	1282920
Pubmed	Mps1 kinase-dependent Sgo2 centromere localisation mediates cohesin protection in mouse oocyte meiosis I.	BUB1 BUB1B	3.19e-05	3	114	2	28947820
Pubmed	Early growth response 1 (Egr-1) directly regulates GABAA receptor α2, α4, and θ subunits in the hippocampus.	GABRB2 GABRB3 SLC32A1	4.37e-05	21	114	3	25708312
Pubmed	Identification of new ciliary signaling pathways in the brain and insights into neurological disorders.	GABRB2 CACNA1A CACNA1E GABBR2 GRM5 AP2M1 PLCH2 SLC16A7	5.93e-05	405	114	8	38187761
Pubmed	Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment.	GABRB2 GABRB3 RELN AVPR2 GABBR2 GRM5 ADORA2B	6.20e-05	300	114	7	19086053
Pubmed	Synapse and Active Zone Assembly in the Absence of Presynaptic Ca2+ Channels and Ca2+ Entry.	CACNA1A CACNA1E	6.36e-05	4	114	2	32616470
Pubmed	Differential cell surface expression of GABAA receptor alpha1, alpha6, beta2 and beta3 subunits in cultured mouse cerebellar granule cells influence of cAMP-activated signalling.	GABRB2 GABRB3	6.36e-05	4	114	2	11902122
Pubmed	The human homologue of Bub3 is required for kinetochore localization of Bub1 and a Mad3/Bub1-related protein kinase.	BUB1 BUB1B	6.36e-05	4	114	2	9660858
Pubmed	Cleft palate is caused by CNS dysfunction in Gad1 and Viaat knockout mice.	GABRB3 SLC32A1	6.36e-05	4	114	2	20333300
Pubmed	N-glycan alterations are associated with drug resistance in human hepatocellular carcinoma.	MGAT4B MGAT4A	6.36e-05	4	114	2	17488527
Pubmed	Central noradrenaline metabolism in cerebellar ataxic mice.	CACNA1A RELN	6.36e-05	4	114	2	6123371
Pubmed	The E4F protein is required for mitotic progression during embryonic cell cycles.	BUB1 BUB1B	6.36e-05	4	114	2	15226446
Pubmed	A role for the Adenomatous Polyposis Coli protein in chromosome segregation.	BUB1 BUB1B	6.36e-05	4	114	2	11283619
Pubmed	Piezo2 regulates colonic mechanical sensitivity in a sex specific manner in mice.	PIEZO2 SCN10A	6.36e-05	4	114	2	37061508
Pubmed	Differential assembly diversifies GABAA receptor structures and signalling.	GABRB2 GABRB3	6.36e-05	4	114	2	35355020
Pubmed	Inhibitory synapse formation in a co-culture model incorporating GABAergic medium spiny neurons and HEK293 cells stably expressing GABAA receptors.	GABRB2 GABRB3	6.36e-05	4	114	2	25489750
Pubmed	PAR1 thrombin receptor-G protein interactions. Separation of binding and coupling determinants in the galpha subunit.	F2R GNA15	6.36e-05	4	114	2	10644723
Pubmed	Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan.	BUB1 BUB1B	6.36e-05	4	114	2	23242215
Pubmed	Cerebellar granule cell signaling is indispensable for normal motor performance.	CACNA1A CACNA1E	6.36e-05	4	114	2	37141091
Pubmed	GABAA Receptors and the Diversity in their Structure and Pharmacology.	GABRB2 GABRB3	6.36e-05	4	114	2	28528665
Pubmed	Hetero-oligomerization between GABAA and GABAB receptors regulates GABAB receptor trafficking.	GABRB2 GABBR2	6.36e-05	4	114	2	14966130
Pubmed	Defining the molecular basis of BubR1 kinetochore interactions and APC/C-CDC20 inhibition.	BUB1 BUB1B	6.36e-05	4	114	2	20220147
Pubmed	Identification of two evolutionarily conserved genes regulating processing of engulfed apoptotic cells.	CCZ1B CCZ1	6.36e-05	4	114	2	20305638
Pubmed	Mex3a Marks a Slowly Dividing Subpopulation of Lgr5+ Intestinal Stem Cells.	LGR5 LOX	6.36e-05	4	114	2	28285904
Pubmed	Bub1 mediates cell death in response to chromosome missegregation and acts to suppress spontaneous tumorigenesis.	BUB1 BUB1B	6.36e-05	4	114	2	17938250
Pubmed	Chromosomal localization of the human genes for alpha 1A, alpha 1B, and alpha 1E voltage-dependent Ca2+ channel subunits.	CACNA1A CACNA1E	1.06e-04	5	114	2	8825650
Pubmed	Differential expression of GABAA/benzodiazepine receptor subunit mRNAs and ligand binding sites in mouse cerebellar neurons following in vivo ethanol administration: an autoradiographic analysis.	GABRB2 GABRB3	1.06e-04	5	114	2	7643102
Pubmed	The brefeldin A-inhibited GDP/GTP exchange factor 2, a protein involved in vesicular trafficking, interacts with the beta subunits of the GABA receptors.	GABRB2 GABRB3	1.06e-04	5	114	2	15198677
Pubmed	Antinociceptive effect of different types of calcium channel inhibitors and the distribution of various calcium channel alpha 1 subunits in the dorsal horn of spinal cord in mice.	CACNA1A CACNA1E	1.06e-04	5	114	2	15451373
Pubmed	Cloning, expression, and chromosomal localization of a mouse gene homologous to the germ cell migration regulator wunen and to type 2 phosphatidic acid phosphatases.	PLPP2 GNA15	1.06e-04	5	114	2	10662554
Pubmed	γ-Aminobutyric Acid Type A (GABAA) Receptor Subunits Play a Direct Structural Role in Synaptic Contact Formation via Their N-terminal Extracellular Domains.	GABRB2 GABRB3	1.06e-04	5	114	2	27129275
Pubmed	Dissecting the roles of human BUB1 in the spindle assembly checkpoint.	BUB1 BUB1B	1.06e-04	5	114	2	26148513
Pubmed	The postsynaptic density 95/disc-large/zona occludens protein syntenin directly interacts with frizzled 7 and supports noncanonical Wnt signaling.	FZD3 FZD8	1.06e-04	5	114	2	18256285
Pubmed	Gamma-aminobutyric acidB receptors and the development of the ventromedial nucleus of the hypothalamus.	GABRB3 GABBR2	1.06e-04	5	114	2	12115679
Pubmed	Phosphorylation of Cdc20 by Bub1 provides a catalytic mechanism for APC/C inhibition by the spindle checkpoint.	BUB1 BUB1B	1.06e-04	5	114	2	15525512
Pubmed	Protein kinase C is differentially stimulated by Wnt and Frizzled homologs in a G-protein-dependent manner.	FZD3 FZD8	1.06e-04	5	114	2	10395542
Pubmed	Functional disorders of the sympathetic nervous system in mice lacking the alpha 1B subunit (Cav 2.2) of N-type calcium channels.	CACNA1A CACNA1E	1.06e-04	5	114	2	11296258
Pubmed	GABAA receptors: structure, function, pharmacology, and related disorders.	GABRB2 GABRB3	1.06e-04	5	114	2	34417930
Pubmed	Involvement of TRPV1 and TDAG8 in Pruriception Associated with Noxious Acidosis.	GPR65 SCN10A	1.06e-04	5	114	2	27566399
Pubmed	Breast cancer risk associated with genotypic polymorphism of the mitotic checkpoint genes: a multigenic study on cancer susceptibility.	BUB1 BUB1B	1.06e-04	5	114	2	17210994
Pubmed	The mitotic checkpoint protein hBUB3 and the mRNA export factor hRAE1 interact with GLE2p-binding sequence (GLEBS)-containing proteins.	BUB1 BUB1B	1.06e-04	5	114	2	11352911
Pubmed	EBF2 determines and maintains brown adipocyte identity.	RELN CIDEA NNMT	1.18e-04	29	114	3	23499423
Pubmed	Tlx1/3 and Ptf1a control the expression of distinct sets of transmitter and peptide receptor genes in the developing dorsal spinal cord.	GABRB2 GABRB3 GABBR2 GRM5	1.50e-04	81	114	4	22723691
Pubmed	SUMOylated NKAP is essential for chromosome alignment by anchoring CENP-E to kinetochores.	BUB1 BUB1B	1.58e-04	6	114	2	27694884
Pubmed	Modulation of Eg5 activity contributes to mitotic spindle checkpoint activation and Tat-mediated apoptosis in CD4-positive T-lymphocytes.	BUB1 BUB1B	1.58e-04	6	114	2	24488929
Pubmed	An action potential initiation mechanism in distal axons for the control of dopamine release.	CACNA1A CACNA1E	1.58e-04	6	114	2	35324301
Pubmed	Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis.	CACNA1A CACNA1E	1.58e-04	6	114	2	12827191
Pubmed	Evolution of GABA(A) receptor diversity in the human genome.	GABRB2 GABRB3	1.58e-04	6	114	2	10023064
Pubmed	The GABAA Receptor β Subunit Is Required for Inhibitory Transmission.	GABRB2 GABRB3	1.58e-04	6	114	2	29706582
Pubmed	A nucleolar protein RRS1 contributes to chromosome congression.	BUB1 BUB1B	1.58e-04	6	114	2	19465021
Pubmed	The beta2-adaptin clathrin adaptor interacts with the mitotic checkpoint kinase BubR1.	BUB1 BUB1B	1.58e-04	6	114	2	12419313
Pubmed	Direct interaction of gbetagamma with a C-terminal gbetagamma-binding domain of the Ca2+ channel alpha1 subunit is responsible for channel inhibition by G protein-coupled receptors.	CACNA1A CACNA1E	1.58e-04	6	114	2	9238069
GeneFamily	Ring finger proteins\|Membrane associated ring-CH-type fingers	MARCHF9 MARCHF11 MARCHF4	1.24e-05	11	78	3	60
GeneFamily	Mannosyl-glycoprotein N-acetylglucosaminyltransferases	MGAT4B MGAT4A	6.49e-04	9	78	2	435
GeneFamily	G protein-coupled receptors, Class F frizzled	FZD3 FZD8	9.85e-04	11	78	2	286
GeneFamily	Ubiquitin specific peptidases	USP34 USP9Y USP5	1.82e-03	56	78	3	366
GeneFamily	Gamma-aminobutyric acid type A receptor subunits	GABRB2 GABRB3	3.00e-03	19	78	2	563
GeneFamily	G protein-coupled receptors, Class A orphans	GPR65 GPR34 LGR5	4.66e-03	78	78	3	262
Coexpression	CHYLA_CBFA2T3_TARGETS_UP	VPREB1 GPR65 F2R LGR5 ELOVL7 ITPKB SLC32A1 MCTP1 NALCN PLPP2	7.81e-06	388	114	10	M2205
Coexpression	CHYLA_CBFA2T3_TARGETS_UP	VPREB1 GPR65 F2R LGR5 ELOVL7 ITPKB SLC32A1 MCTP1 NALCN PLPP2	1.09e-05	403	114	10	MM1060
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBGABA	GABRB2 GABRB3 CACNA1A CACNA1E DPYSL3 THSD7B GABBR2 CSMD2 GRM5 SLC32A1 NALCN PGAP1 CNGB1	1.20e-05	703	114	13	M39070
Coexpression	GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_DN	CSMD2 ARMC2 KAT7 USP5 IFI44L VAV2 HERC5	2.30e-05	194	114	7	M4227
Coexpression	GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP	GPR34 GPN1 POLR1D LPAR6 SCTR GNA15 CERS4	2.71e-05	199	114	7	M9214
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HSERT	GABRB2 CACNA1A CACNA1E DPYSL3 THSD7B GABBR2 GRM5 NALCN PLCH2 CNGB1	2.79e-05	450	114	10	M39072
Coexpression	GSE30083_SP2_VS_SP4_THYMOCYTE_UP	GABRB3 CCR9 THSD7B ADORA2B NALCN PLCH2 EVI5L	2.80e-05	200	114	7	M5034
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	CACNA1A RELN THSD7B GABBR2 CSMD2 GRM5 NKAIN3	1.70e-07	159	113	7	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	COVID-19-kidney-Technical/muscle_(PCT)\|kidney / Disease (COVID-19 only), tissue and cell type	CACNA1A RELN THSD7B CSMD2 GRM5 NKAIN3	2.00e-06	146	113	6	c55f1bdb6ac43b4118cb27ea7c879527e1afcbab
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1A RELN THSD7B CSMD2 GRM5 NKAIN3	2.16e-06	148	113	6	d6ac5972267254651dfbe16bb4e9a62228093cc7
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|kidney / Disease (COVID-19 only), tissue and cell type	CACNA1A RELN THSD7B GABBR2 PIEZO2 NKAIN3	3.78e-06	163	113	6	19c28ce16a588a7f4a035c32726f6ccd67702b5b
ToppCell	Bronchial_Biopsy-Endothelial-Lymphatic\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	RELN CYB5RL AVPR2 PIEZO2 NNMT HERC5	5.15e-06	172	113	6	c41f5a66781bbf63afce7ca5d118cc6d8e0fe0bc
ToppCell	Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)\|Adult / Lineage, Cell type, age group and donor	GABRB3 CACNA1A DPYSL3 PIEZO2 NALCN MARCHF4	5.69e-06	175	113	6	4db1a3c284488b3f6de7568363f176d74e2a4587
ToppCell	Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231\|Adult / Lineage, Cell type, age group and donor	GABRB3 CACNA1A DPYSL3 PIEZO2 NALCN MARCHF4	5.69e-06	175	113	6	8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18
ToppCell	Epithelial-lung_neuroendocrine_cell_(PNEC)\|World / Lineage, Cell type, age group and donor	GABRB3 CACNA1A DPYSL3 NALCN MARCHF11 MARCHF4	7.12e-06	182	113	6	57bf4ffb304324e2e392e196336a530d9f78fe0d
ToppCell	3'-Child09-12-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DPYSL3 RELN PIEZO2 NALCN LOX EDDM13	7.82e-06	185	113	6	9de1db2ce9e44956b1214daf6e1e161334679c88
ToppCell	3'-Child09-12-SmallIntestine-Endothelial-lymphatic_endothelial\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DPYSL3 RELN PIEZO2 NALCN LOX EDDM13	7.82e-06	185	113	6	18f5d9438c76e37988a7d17aa2a080af6bedbfc4
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GABRB2 CACNA1A RELN KIAA0513 MCTP1 PLCH2	8.06e-06	186	113	6	d1d01ce46e62944aa9864eda47e8401b5f0d2bdc
ToppCell	5'-Adult-Distal_Rectal-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNA1E RELN AVPR2 PIEZO2 NALCN EDDM13	8.57e-06	188	113	6	524a12f433c7b6f33fad36c0716afa06cd3235e9
ToppCell	5'-Adult-Distal_Rectal-Endothelial-lymphatic_endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNA1E RELN AVPR2 PIEZO2 NALCN EDDM13	8.57e-06	188	113	6	d2610b81b3c7f22977b5e2137b1f61410fc4ef16
ToppCell	Entopeduncular-Neuronal\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	GABRB3 CACNA1E KIAA0513 ZDBF2 MCTP1 MARCHF4	9.66e-06	192	113	6	4c35e5c28a40b439044797ba1f06cb7c36b2a8de
ToppCell	5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DPYSL3 RELN PIEZO2 NALCN LOX EDDM13	9.95e-06	193	113	6	bd0027fa97de41ae22ff64a61c8e217496f122ca
ToppCell	3'-Broncho-tracheal-Endothelial-Blood_vessel_EC\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AVPR2 ELOVL7 MCTP1 LPAR6 APLNR IFI44L	1.02e-05	194	113	6	3446bbe12767fc2006c5d6a39758f31d8f899409
ToppCell	3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AVPR2 ELOVL7 MCTP1 LPAR6 APLNR IFI44L	1.02e-05	194	113	6	21854ead32c06c8dbd0e4f26b0dd82fdaadb98a8
ToppCell	3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AVPR2 ELOVL7 MCTP1 LPAR6 APLNR IFI44L	1.02e-05	194	113	6	87db3a66da47728d1d649a56256517d7e137de5f
ToppCell	3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AVPR2 ELOVL7 MCTP1 LPAR6 APLNR IFI44L	1.02e-05	194	113	6	ce630a196e1c39b29e49f843ec016b053027d59e
ToppCell	Bronchial-NucSeq-Stromal-Schwann-Schwann_Myelinating\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1A RELN MBOAT7 PIEZO2 OSCP1 NKAIN3	1.09e-05	196	113	6	efeb272bc9e37e60d15d056b7574991c5c7501bc
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer-37\|World / Primary Cells by Cluster	GABRB2 CACNA1E DPYSL3 GABBR2 GRM5 CIDEA	1.12e-05	197	113	6	00d756bc0231e1b3b88430214338c1059cb11106
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GABRB2 GABRB3 CACNA1A GABBR2 GRM5 FOCAD	1.15e-05	198	113	6	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GABRB2 GABRB3 CACNA1A GABBR2 GRM5 FOCAD	1.15e-05	198	113	6	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GABRB2 GABRB3 CACNA1A GABBR2 GRM5 FOCAD	1.15e-05	198	113	6	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RELN CYB5RL PIEZO2 NALCN LOX EDDM13	1.15e-05	198	113	6	5d42f4fda2081ea3e9f62a00e7eea702e0d0be7d
ToppCell	5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RELN CYB5RL PIEZO2 NALCN LOX EDDM13	1.15e-05	198	113	6	99d6a64f3410dae3019161feef20a8f06081a24b
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	GABRB2 GABRB3 CACNA1E RELN GABBR2 SLC32A1	1.22e-05	200	113	6	2f481e2fd248c02a5aa2e0248c16808df142fed2
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-CALB1--L1-3\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CACNA1A DNAH17 MARCHF4 MUSK VAV2 HERC5	1.22e-05	200	113	6	f3c710f0fc8a7bfb5371d1aff6e3d8f266953153
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	GABRB2 GABRB3 CACNA1E RELN GABBR2 SLC32A1	1.22e-05	200	113	6	bd4b9f6b37f4a3c960c4149cf0cfd2caf3327d2d
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	GABRB2 GABRB3 CACNA1A GABBR2 GRM5 FOCAD	1.22e-05	200	113	6	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-CALB1-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CACNA1A DNAH17 MARCHF4 MUSK VAV2 HERC5	1.22e-05	200	113	6	70a06fd7fb8de2c8ec3e3182e4476ced049daeae
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	GABRB2 GABRB3 CACNA1E RELN GABBR2 SLC32A1	1.22e-05	200	113	6	dc674124475edf83908b51a4e1454bc2dc4f06fa
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-CALB1\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CACNA1A DNAH17 MARCHF4 MUSK VAV2 HERC5	1.22e-05	200	113	6	1639982d9d994918f7912d12d9d7cfcbc9da4145
ToppCell	COVID-19-kidney-Technical/muscle_(EC)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1A VPREB1 RELN THSD7B GABBR2	1.89e-05	128	113	5	91072ca56bce2c552a95edd67e17f43d8cc1de95
ToppCell	LPS-antiTNF-Hematopoietic_Meg-Ery-Mes-Epi-like\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1A ATP13A4 GRM5 BUB1B C5	2.53e-05	136	113	5	a2063abe2d7c3277bfbe1514c8c66363cf04b248
ToppCell	COVID-19-kidney-Technical/muscle_(EC)\|kidney / Disease (COVID-19 only), tissue and cell type	CACNA1A VPREB1 RELN THSD7B GABBR2	2.81e-05	139	113	5	64c35411bbe67acb5010dadc4b0b1be0f8b17737
ToppCell	VE-CD8-antiviral_CD4\|VE / Condition, Cell_class and T cell subcluster	LIPJ F2R IFI44L HERC5 EDDM13	3.80e-05	148	113	5	f49f579650b57cc4c6c7a7fa726447740d3dc695
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1A RELN THSD7B GRM5 NKAIN3	4.05e-05	150	113	5	0205318a870e091add66ee4305747dda9f51510d
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasmablast\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	VPREB1 PLCH2 BUB1 BUB1B	4.21e-05	76	113	4	df1c29cf88b1957e210058e172683f78a1eea2bd
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GABRB3 GRM5 PLPP2 PGAP1 MARCHF4	4.45e-05	153	113	5	edf5d026e8e4c685b7c369d70894741bb2cd568e
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GABRB3 GRM5 PLPP2 PGAP1 MARCHF4	4.45e-05	153	113	5	3240d4d690335ba22317b1f3d33f9ea069e93838
ToppCell	Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1\|Hippocampus / BrainAtlas - Mouse McCarroll V32	CCR9 SPO11 SLC22A8 LOX MUSK	5.34e-05	159	113	5	92049a8d8fc9997d8d0d76500c72596a9b2394e0
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DPYSL3 RELN PIEZO2 NALCN LOX	5.67e-05	161	113	5	fb59d96c2aa9e4654f02bf6ce36bf832776cb4dd
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DPYSL3 RELN PIEZO2 NALCN LOX	5.67e-05	161	113	5	c53c461fc721a7960cef86662f49e2a495520701
ToppCell	COVID-19-kidney-Lymphatic_EC\|kidney / Disease (COVID-19 only), tissue and cell type	DPYSL3 RELN PIEZO2 MCTP1 OR7D2	6.74e-05	167	113	5	97d0fea1f41c1c00e36d9b5c4c1f0dd85087056f
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CACNA1A GPR34 MGAT4A LPAR6 IFI44L	6.74e-05	167	113	5	942134bbabe9972fae80cbc4ed4e94da52f55dc3
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CIDEA SLC32A1 PLPP2 NKAIN3 VAV2	6.93e-05	168	113	5	f3879a8e11eaf866f37c52e67021be43f0b8784a
ToppCell	Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	GABRB3 CACNA1A CACNA1E CSMD2 MARCHF4	7.13e-05	169	113	5	b6b5bb6408c1305a00719e1b88a5e1202081faf3
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	UXS1 B4GAT1 S100A5 LPAR6 IFI44L	7.33e-05	170	113	5	51dbfa07daf6f972b566f3f6abe7f46e080ec01c
ToppCell	5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RELN PIEZO2 NALCN LOX EDDM13	7.96e-05	173	113	5	7dc988fc0ba29990567bf1bcdeb3faeeee507eb1
ToppCell	3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GABRB3 CACNA1A GABBR2 ADORA2B MARCHF4	8.18e-05	174	113	5	a62531ebf16b32b249168dca11b870f63a8aa81c
ToppCell	3'-Child09-12-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GABRB2 LGR5 ADORA2B PLPP2 PGAP1	8.40e-05	175	113	5	0431897d7fcc9cefb516cd36987cf18b7f19a26a
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN THSD7B SLC32A1 SCTR NKAIN3	9.10e-05	178	113	5	3c973aac16988e88f5677d3d695dd772ccfd6570
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ATP13A4 FZD8 ADORA2B APLNR IFI44L	9.85e-05	181	113	5	0c3f469bed108994ed696230e3c30343f7a301d3
ToppCell	Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Nnat_(Nnat)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	VPREB1 CCR9 SPO11 MUSK	1.01e-04	95	113	4	3699ea16660a22ea79fecfea56ece2dfb0f13467
ToppCell	Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	VPREB1 CCR9 SPO11 MUSK	1.01e-04	95	113	4	cbfe615d880913bafaf5e7e8d24c3ec14a9351ce
ToppCell	Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Nnat_(Nnat)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	VPREB1 CCR9 SPO11 MUSK	1.01e-04	95	113	4	27ac23b87747434a3084cc087e7b884e68f0eab9
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-medium_spiny_neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GABRB3 CACNA1E GRM5 SLC32A1 MCTP1	1.01e-04	182	113	5	d41ff834b8fc1d0e23cac7ae261de5f72874e462
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-SPN_Neuron_STR\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GABRB3 CACNA1E GRM5 SLC32A1 MCTP1	1.01e-04	182	113	5	6cde859edfe7607bd7ada89d20258413d06f4207
ToppCell	PCW_13-14-Neuronal\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	GABRB3 RELN CSMD2 NKAIN3 CNGB1	1.06e-04	184	113	5	65cf3460125e3dbc34978957bc138a449f71f7df
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN THSD7B SLC32A1 SCTR NKAIN3	1.06e-04	184	113	5	32473dbdb2de66391157c5814ef34e790806e4f2
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN THSD7B SLC32A1 SCTR NKAIN3	1.09e-04	185	113	5	bdfa8c284bbc5e85c806327fbb7778cf16242a38
ToppCell	droplet-Thymus-nan-3m-Lymphocytic-double_negative_T_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPR65 CCR9 QSOX1 LOX NKAIN3	1.12e-04	186	113	5	11929e36d8c9b4c4bc2f5e912f139f474f91ab00
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN SLC32A1 PIEZO2 MARCHF11 VAV2	1.12e-04	186	113	5	96f6603cc75fa1ffc2a2fdb94ec0ec09498e540a
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-Pulmonary_neuroendocrine\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	GABRB3 CACNA1A DPYSL3 ELOVL7 MARCHF4	1.12e-04	186	113	5	fcabebdfbf1b1dbb35ce2b3c53a60d2b1aed8e6c
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ATP13A4 ITPKB FZD8 APLNR IFI44L	1.15e-04	187	113	5	2b1b2c3792d6c9ab69675ce88842bb589414b530
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GABRB2 CACNA1A RELN MCTP1 PLCH2	1.15e-04	187	113	5	1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41
ToppCell	Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	GPR34 MGAT4A MCTP1 LPAR6 GNA15	1.15e-04	187	113	5	39b99f46b723f7f3c44880d7fe8642cbad558b8a
ToppCell	PCW_10-12-Epithelial-Epithelial_neuroendo-epi_neuroendocrine1[NE1]_(11)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	GABRB3 CACNA1E NALCN MARCHF11 MARCHF4	1.15e-04	187	113	5	98477ba04a42a8da80a72f41a182429f46283595
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	USP34 CACNA1E ZDBF2 SLC32A1 MARCHF4	1.18e-04	188	113	5	b73e8a40393c3f656e2fcfe395a761b1f985c254
ToppCell	Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	GABRB3 CACNA1A NALCN MARCHF11 MARCHF4	1.18e-04	188	113	5	c4c3b21ab723b0e9beff9ec84f8d68485f771528
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-medium_spiny_neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GABRB3 CACNA1E GRM5 SLC32A1 MCTP1	1.21e-04	189	113	5	3e8e30160a8d6f531ff743cb5918c9e79481f1bd
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-SPN_Neuron_STR\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GABRB3 CACNA1E GRM5 SLC32A1 MCTP1	1.21e-04	189	113	5	851f8144aed5c7f80302911cd6b03f14bde7b56d
ToppCell	TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Micropapillary_Adenocarcinoma\|TCGA-Lung / Sample_Type by Project: Shred V9	EAPP TCP11 GABBR2 GRM5	1.23e-04	100	113	4	8743eadbe35a1fda5ca87d8901de35c573d268ef
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN THSD7B F2R SLC32A1 NKAIN3	1.24e-04	190	113	5	3b8d1e66ae68c1eee64095e75195d76d97e24026
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D175\|Adult / Lineage, Cell type, age group and donor	DPYSL3 GRM5 PIEZO2 NNMT SLC16A7	1.24e-04	190	113	5	7dcca3469f3a3b70db0420cb94f7765f39492f06
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GABRB3 CACNA1E GRM5 SLC32A1 MCTP1	1.24e-04	190	113	5	1c5cf933ce71fed5638b9ef31eb81f6c2b6dadbc
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN THSD7B F2R SLC32A1 NKAIN3	1.24e-04	190	113	5	dc655e4782aab274f0c9b6e36a5ce315e3a1a4b9
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN THSD7B SLC32A1 SCTR NKAIN3	1.27e-04	191	113	5	06760c3bb40e4f66879a5f5e09c9abfce4ebbba3
ToppCell	Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	GPR34 MGAT4A MCTP1 LPAR6 GNA15	1.27e-04	191	113	5	24d75b7e1d6fb9d24aa7844f584ee888a449841f
ToppCell	ILEUM-inflamed-(1)_T_cell-(1)_Th17_Trm\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	GPR65 GPR34 MGAT4A GNA15 IFI44L	1.30e-04	192	113	5	12f7ea575da5d650c740e6060f5dab0478e563dd
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN THSD7B F2R SLC32A1 NKAIN3	1.30e-04	192	113	5	342842378c20267c5044bdd622515e8b9f895623
ToppCell	LAM-Endothelial-LymEndo\|LAM / Condition, Lineage and Cell class	DPYSL3 RELN F2R PIEZO2 LOX	1.33e-04	193	113	5	68eadc91c2d89edd2412e86dfe134dd7c0ef6ee9
ToppCell	COPD-Endothelial-Lymphatic\|COPD / Disease state, Lineage and Cell class	DPYSL3 RELN PIEZO2 LOX NNMT	1.33e-04	193	113	5	18bcf08068a236c4575c7a07181ac893dfdcbeeb
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-Z\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	GPR65 GPR34 MGAT4A LPAR6 IFI44L	1.33e-04	193	113	5	fc2eb6a7b4f1e687bf37e59e3cd52b14f99ffea4
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	DPYSL3 CSMD2 PIEZO2 NALCN MUSK	1.36e-04	194	113	5	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	Hippocampus-Neuronal\|Hippocampus / BrainAtlas - Mouse McCarroll V32	GABRB2 GABRB3 USP34 GABBR2 GRM5	1.36e-04	194	113	5	8aeb347b3024354c9505f4f0fddf0b843489dc6b
ToppCell	3'-Child09-12-SmallIntestine-Epithelial-epithelial_progenitor_cell\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GABRB2 LGR5 ADORA2B PLPP2 PGAP1	1.36e-04	194	113	5	46e522ca59db545d1eb0c27cd4361f19d4f8f762
ToppCell	ASK440-Endothelial-Lymphatic\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	DPYSL3 RELN F2R PIEZO2 NNMT	1.36e-04	194	113	5	4aa68e39e36094359dfbedf1e9bdf3ea5c32ed1a
ToppCell	3'-Broncho-tracheal-Endothelial\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AVPR2 ELOVL7 LPAR6 APLNR IFI44L	1.36e-04	194	113	5	8b6d13cfd04f7ff0847ad7cfbbca4e66e07b8344
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CACNA1A THSD7B GABBR2 CSMD2 SCN10A	1.40e-04	195	113	5	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CACNA1A THSD7B GABBR2 CSMD2 SCN10A	1.40e-04	195	113	5	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	GPR34 MGAT4A MCTP1 LPAR6 GNA15	1.40e-04	195	113	5	312d9625655b38f1a7c2bf8f8bb7b667ebdf9617
ToppCell	5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DPYSL3 RELN AVPR2 NALCN NNMT	1.40e-04	195	113	5	590c0dc0db4dc62879645ed7f61292ff97d2c7d5
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GABRB2 GABRB3 FZD3 GABBR2 FOCAD	1.40e-04	195	113	5	2e1df01bf6e4e98e6cd9fb50926e34c5077b8666
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GABRB2 GABRB3 GABBR2 GRM5 FOCAD	1.43e-04	196	113	5	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	GRM5 PLPP2 PLCH2 C5 CNGB1	1.46e-04	197	113	5	751f19b00f92e1334f653b870d3f7c0c149ff41a
ToppCell	10x3'2.3-week_17-19-Endothelial-stroma-sinusoidal_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	F2R PIEZO2 LPAR6 APLNR IFI44L	1.46e-04	197	113	5	4e58bbf3ecb30b4c8199adcc04d2eb134d90de56
ToppCell	Parenchyma_Control_(B.)-Epithelial-TX-Basal_1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	GRM5 PLPP2 PLCH2 C5 CNGB1	1.46e-04	197	113	5	2701864e49878c5f323f5133e2c4b0a5a7fff7f5
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-ventral_progenitors_and_neurons_1\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	GABRB2 GABRB3 GABBR2 GRM5 SLC32A1	1.46e-04	197	113	5	4961f66606f08e399508fd6cabca588e7ab406a8
Drug	2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A	HSDL2 ADORA2B TMEM106B PLPP2 SUPT4H1 BUB1 ST6GALNAC4 C5 SLC16A7	4.31e-07	192	111	9	1647_DN
Drug	DCG-IV	CACNA1A CACNA1E GABBR2 GRM5 SLC32A1 ADORA2B	1.00e-06	68	111	6	CID000115114
Drug	APMPA	CACNA1A CACNA1E GABBR2	3.89e-06	7	111	3	CID000512300
Drug	baclofen	GABRB2 GABRB3 CACNA1A CACNA1E GABBR2 GRM5 SLC32A1 ADORA2B	4.47e-06	191	111	8	CID000002284
Drug	Estriol [50-27-1]; Down 200; 13.8uM; PC3; HT_HG-U133A	MGAT4B KIAA0513 MORC2 GABBR2 MCTP1 SUPT4H1 C5 AQR	6.05e-06	199	111	8	5866_DN
Drug	nimodipine	GABRB2 CACNA1A CACNA1E DPYSL3 GABBR2 GRM5 CERS4	7.18e-06	145	111	7	CID000004497
Drug	AC1Q5UBL	GABRB2 GABRB3 GABBR2 GRM5 STT3A SLC32A1 ADORA2B	7.51e-06	146	111	7	CID000005466
Drug	3-aminopropylphosphinic acid	GABRB2 CACNA1A CACNA1E GABBR2	1.73e-05	32	111	4	CID006335948
Drug	NO-711	GABRB2 B4GAT1 GABBR2 GRM5 SLC32A1	1.77e-05	66	111	5	CID000004515
Drug	gabapentin	GABRB2 GABRB3 CACNA1A CACNA1E GABBR2 GRM5 SCN10A	1.95e-05	169	111	7	CID000003446
Drug	riluzole	GABRB2 GABRB3 CACNA1A CACNA1E GABBR2 GRM5 SCN10A	2.35e-05	174	111	7	CID000005070
Drug	flurazepam	GABRB2 GABRB3 GABBR2 SLC32A1	2.49e-05	35	111	4	CID000003393
Drug	1,3-dipropylxanthine	CACNA1A CACNA1E GABBR2 GRM5 ADORA2B	3.10e-05	74	111	5	CID000169317
Drug	4-aminopyrrolidine-2,4-dicarboxylate	CACNA1E GRM5 STT3A ADORA2B	3.86e-05	39	111	4	CID003331970
Drug	myo-inositol	CACNA1A CACNA1E VPREB1 GPR65 AVPR2 GPN1 GRM5 F2R ITPKB ADORA2B PLPP2 LPAR6 PGAP1 GNA15	4.05e-05	811	111	14	CID000000892
Drug	3-Acetamidocoumarin [779-30-6]; Up 200; 19.6uM; PC3; HT_HG-U133A	CYB5RL NIPAL3 MFAP3 LOX DNAH17 NNMT VAV2	5.36e-05	198	111	7	4601_UP
Drug	Fluphenazine dihydrochloride [146-56-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A	GABBR2 NIPAL3 WNK1 ITPKB USP5 PLCH2 SCN10A	5.53e-05	199	111	7	7234_UP
Drug	Cocaine	GABRB2 GABRB3 DPYSL3 UXS1 GABBR2 GRM5 ITPKB CIDEA SLC32A1 ADORA2B AP2M1 PLPP2 CCZ1 LOX APLNR SCN10A ST6GALNAC4 MUSK	6.40e-05	1314	111	18	ctd:D003042
Drug	dehydroepiandrosterone sulfate	GABRB2 GABRB3 ABCC11 GABBR2 ADORA2B SLC22A8 LPAR6 OSCP1	6.49e-05	277	111	8	CID000005244
Disease	glycerate measurement	CCR9 THSD7B MCTP1	2.28e-05	15	111	3	EFO_0021029
Disease	familial hemiplegic migraine 1 (implicated_via_orthology)	CACNA1A CACNA1E	4.20e-05	3	111	2	DOID:0111181 (implicated_via_orthology)
Disease	migraine (implicated_via_orthology)	CACNA1A CACNA1E	8.37e-05	4	111	2	DOID:6364 (implicated_via_orthology)
Disease	longitudinal BMI measurement, non-small cell lung carcinoma	CACNA1A SLC16A7	8.37e-05	4	111	2	EFO_0003060, EFO_0005937
Disease	Warburton Anyane Yeboa syndrome	BUB1 BUB1B	1.39e-04	5	111	2	C2931286
Disease	Mosaic variegated aneuploidy syndrome 1	BUB1 BUB1B	1.39e-04	5	111	2	C1850343
Disease	sphingomyeline C18:1 measurement	MUSK CERS4	1.39e-04	5	111	2	EFO_0801320
Disease	non-small cell lung carcinoma	THSD7B PIEZO2 NALCN MUSK	1.88e-04	75	111	4	EFO_0003060
Disease	Sphingomyelin (d18:1/20:1, d18:2/20:0) measurement	MUSK CERS4	2.08e-04	6	111	2	EFO_0022110
Disease	Sphingomyelin (d18:1/18:1, d18:2/18:0) measurement	MUSK CERS4	2.08e-04	6	111	2	EFO_0022108
Disease	level of Phosphatidylinositol (18:1_18:2) in blood serum	MBOAT7 MUSK	2.08e-04	6	111	2	OBA_2045160
Disease	ARTHROGRYPOSIS, DISTAL, TYPE 2B	PIEZO2 NALCN	2.08e-04	6	111	2	C1834523
Disease	1-arachidonoyl-GPI (20:4) measurement	MBOAT7 MUSK	2.91e-04	7	111	2	EFO_0800256
Disease	1-linoleoyl-GPI (18:2) measurement	MBOAT7 MUSK	2.91e-04	7	111	2	EFO_0800266
Disease	1-palmitoyl-2-linoleoyl-GPI (16:0/18:2) measurement	MBOAT7 MUSK	2.91e-04	7	111	2	EFO_0800609
Disease	Akinetic Petit Mal	GABRB3 CACNA1A	2.91e-04	7	111	2	C0001890
Disease	Epilepsy, Absence, Atypical	GABRB3 CACNA1A	2.91e-04	7	111	2	C0751124
Disease	Absence Seizure Disorder	GABRB3 CACNA1A	2.91e-04	7	111	2	C4553705
Disease	Juvenile Absence Epilepsy	GABRB3 CACNA1A	2.91e-04	7	111	2	C4317339
Disease	Childhood Absence Epilepsy	GABRB3 CACNA1A	2.91e-04	7	111	2	C4281785
Disease	level of Sphingomyelin (d36:2) in blood serum	MUSK CERS4	2.91e-04	7	111	2	OBA_2045177
Disease	Epilepsy, Minor	GABRB3 CACNA1A	2.91e-04	7	111	2	C4552765
Disease	Absence Epilepsy	GABRB3 CACNA1A	2.91e-04	7	111	2	C0014553
Disease	hereditary ataxia (implicated_via_orthology)	CACNA1A CACNA1E	2.91e-04	7	111	2	DOID:0050951 (implicated_via_orthology)
Disease	Distal arthrogryposis	PIEZO2 NALCN	4.96e-04	9	111	2	cv:C0265213
Disease	1-palmitoyl-2-arachidonoyl-GPI (16:0/20:4) measurement	MBOAT7 MUSK	4.96e-04	9	111	2	EFO_0800412
Disease	1-stearoyl-2-oleoyl-GPI (18:0/18:1) measurement	MBOAT7 MUSK	6.19e-04	10	111	2	EFO_0800469
Disease	meningitis	CACNA1E ITPKB	7.54e-04	11	111	2	MONDO_0021108
Disease	phosphatidylcholine 32:0 measurement	GABRB3 MUSK	7.54e-04	11	111	2	EFO_0010372
Disease	glycerophospholipid measurement	MBOAT7 MUSK CERS4	8.42e-04	49	111	3	EFO_0007630
Disease	level of Phosphatidylinositol (18:0_20:3) in blood serum	MBOAT7 MUSK	9.03e-04	12	111	2	OBA_2045157
Disease	Influenza	SLC22A8 IFI44L HERC5	1.00e-03	52	111	3	C0021400
Disease	1-stearoyl-2-linoleoyl-GPI (18:0/18:2) measurement	MBOAT7 MUSK	1.06e-03	13	111	2	EFO_0800413
Disease	Hereditary Motor and Sensory-Neuropathy Type II	MORC2 WNK1	1.06e-03	13	111	2	C0270914
Disease	1-stearoyl-2-dihomo-linolenoyl-GPI (18:0/20:3n3 or 6) measurement	MBOAT7 MUSK	1.24e-03	14	111	2	EFO_0022085
Disease	diacylglycerol 38:4 measurement	MBOAT7 MUSK	1.24e-03	14	111	2	EFO_0020066
Disease	Hermansky-Pudlak syndrome (implicated_via_orthology)	CCZ1B CCZ1	1.24e-03	14	111	2	DOID:3753 (implicated_via_orthology)
Disease	Yu-Zhi constitution type	GABRB2 PIEZO2	1.43e-03	15	111	2	EFO_0007638
Disease	brain edema (biomarker_via_orthology)	F2R C5	1.43e-03	15	111	2	DOID:4724 (biomarker_via_orthology)
Disease	phosphatidate measurement	MBOAT7 MUSK	1.43e-03	15	111	2	EFO_0020047
Disease	Neuralgia, Supraorbital	GRM5 SCN10A	1.63e-03	16	111	2	C0038870
Disease	Neuralgia	GRM5 SCN10A	1.63e-03	16	111	2	C0027796
Disease	1-stearoyl-2-arachidonoyl-GPI (18:0/20:4) measurement	MBOAT7 MUSK	1.63e-03	16	111	2	EFO_0800184
Disease	Neuralgia, Atypical	GRM5 SCN10A	1.63e-03	16	111	2	C0234247
Disease	Neuralgia, Stump	GRM5 SCN10A	1.63e-03	16	111	2	C0234249
Disease	Neuralgia, Iliohypogastric Nerve	GRM5 SCN10A	1.63e-03	16	111	2	C0423712
Disease	Neuralgia, Perineal	GRM5 SCN10A	1.63e-03	16	111	2	C0423711
Disease	Paroxysmal Nerve Pain	GRM5 SCN10A	1.63e-03	16	111	2	C0751373
Disease	Nerve Pain	GRM5 SCN10A	1.63e-03	16	111	2	C0751372
Disease	Neuralgia, Ilioinguinal	GRM5 SCN10A	1.63e-03	16	111	2	C0751371
Disease	Neuralgia, Vidian	GRM5 SCN10A	1.63e-03	16	111	2	C0042656
Disease	response to ketamine	MROH2B MARCHF11 NKAIN3	2.27e-03	69	111	3	EFO_0009748
Disease	level of Sphingomyelin (d38:2) in blood serum	MUSK CERS4	2.30e-03	19	111	2	OBA_2045179
Disease	diacylglycerol 38:3 measurement	MBOAT7 MUSK	2.30e-03	19	111	2	EFO_0020065
Disease	anorexia nervosa	TMEM106B QSOX1 MCTP1	2.36e-03	70	111	3	MONDO_0005351
Disease	level of Phosphatidylinositol (18:0_18:2) in blood serum	MBOAT7 MUSK	2.81e-03	21	111	2	OBA_2045156
Disease	unipolar depression, bipolar disorder	CACNA1E ATP13A4 GRM5 TMEM106B	2.90e-03	156	111	4	EFO_0003761, MONDO_0004985
Disease	amblyopia	CACNA1E CNGB1	3.08e-03	22	111	2	MONDO_0001020
Disease	level of Phosphatidylinositol (18:0_20:4) in blood serum	MBOAT7 MUSK	3.37e-03	23	111	2	OBA_2045158

Protein segments in the cluster

Peptide	Gene	Start	Entry
RVAETMCYAYMKQEG	UXS1	236	Q8NBZ7
MCYAYMKQEGVEVRV	UXS1	241	Q8NBZ7
MMYCKEKIYAGVGEF	BUB1B	396	O60566
VLMMKFYGASVAYEN	CACNA1A	1581	O00555
MAELGLCIYQFEYML	EVI5L	236	Q96CN4
SSDYLLEACKMVNYM	CERS4	241	Q9HA82
VAATVYCMLFGTYMK	BUB1	991	O43683
YCMLFGTYMKVKNEG	BUB1	996	O43683
NKTVTYQCVPGYMME	CSMD2	2971	Q7Z408
NTVVLMMKYYSAPCT	CACNA1E	1491	Q15878
MQMSYAIRCAFYQLL	B4GAT1	1	O43505
CLFENVVPMSYMVYF	ADORA2B	171	P29275
ALVTSFCMFKYMALY	ATP13A4	896	Q4VNC1
MEAFLYCMGSIKFIS	ARMC2	391	Q8NEN0
IKDKGVNSFMVYMAY	DPYSL3	156	Q14195
LCKVVGTLFYMNMYI	GPR34	126	Q9UPC5
ESYKTQYRAMFVMNC	EAPP	196	Q56P03
ELSAYCEGYFLKNMM	BTBD11	1041	A6QL63
LGEAEYVVALFMYMC	AQR	1201	O60306
FMGLLAMYTYFQAKI	QSOX1	721	O00391
DKSIFYFSCMMQYFL	OR5D14	91	Q8NGL3
LMTMCFTYYHIGKPQ	KIAA0513	181	O60268
TTKVQCYMDYSMVAT	APLNR	176	P35414
TKQNLDYCFLMMYAQ	MGAT4A	236	Q9UM21
DYCFLMMYAQEKGIY	MGAT4A	241	Q9UM21
MMDDYTYVSVTGCIV	NKAIN3	126	Q8N8D7
MYVVAMVGNCGLLYL	OR52N4	36	Q8NGI2
YMCEFCLKYMKSQTI	KAT7	366	O95251
QLDYPIFYVMFVCMV	NIPAL3	236	Q6P499
KMGFVINAIYSMAYG	GRM5	396	P41594
QISSLKAEDMAMYYC	IGHV7-81	101	A0A0B4J1V7
MKRCVMVLVNAAYYV	MCTP1	781	Q6DN14
NLDYCFLMMYAQSKG	MGAT4B	246	Q9UQ53
DKICLNILFMMFGYD	LIPJ	221	Q5W064
RQGCTITMAYIDYNM	IFI44L	46	Q53G44
GFLVIMDALKSSYYM	NNMT	191	P40261
VICFIYYMMFKKAIG	ABCC11	971	Q96J66
EVLIKCYQMGLMSRY	CYB5RL	141	Q6IPT4
LVDLTGEYKYMYMSC	SLC16A7	396	O60669
GEYKYMYMSCGAIVV	SLC16A7	401	O60669
FLKMRAYDYMCMGFV	MBOAT7	401	Q96N66
CAYTIAKYGMSMYVL	HSDL2	166	Q6YN16
YVKAIDMYLMGCFVF	GABRB2	301	P47870
PYVKAIDMYLMGCFV	GABRB3	301	P28472
KYTLYGCMFSMVFVL	LPAR6	16	P43657
FLYKMCDVMAAYFGK	AP2M1	81	Q96CW1
FILDMYTRMYTGCVD	GNA15	311	P30679
FGMYCMVFLALYVQA	PLPP2	171	O43688
FMSNMLYACSILYKT	GPN1	166	Q9HCN4
QDLLFQICYGMYGFM	MARCHF9	216	Q86YJ5
IFTSGDMSVYYMIVC	MFAP3	141	P55082
YMIQFSLVMGCGQKY	RELN	926	P78509
GMFIYNCSRLIKMYE	MORC2	381	Q9Y6X9
AFYCNMYASILLMTV	F2R	181	P25116
YCLFAEMIQPEYGMF	HERC5	731	Q9UII4
DISYMGCLTQVYFLM	OR7D4	91	Q8NG98
PDYAVFMLKYFMCLV	FZD8	581	Q9H461
TMVYVFNCSEQMDYK	DNAH17	1866	Q9UFH2
MNSKMQVYSGSKCAY	ELOA	556	Q14241
QVYSGSKCAYLPKMM	ELOA	561	Q14241
VLFSVYMCYEFVMSG	ELOVL7	76	A1L3X0
YNYRTSGMQFCVKMS	C5	846	P01031
VYKAMSAAVCFMIDA	CCZ1	316	P86791
VVNSMYKMNFYSCVL	CCR9	121	P51686
YKMNFYSCVLLIMCI	CCR9	126	P51686
VYKAMSAAVCFMIDA	CCZ1B	316	P86790
FLKCAYMVMTYLFVS	EDDM13	121	A0A1B0GTR0
LLFQICYGMYGFMDV	MARCHF4	271	Q9P2E8
KDILFQICYGMYGFM	MARCHF11	276	A6NNE9
TYVQKMSMYNLRCAA	LOX	226	P28300
YAVCYMMVSLIFFIG	FZD3	241	Q9NPG1
YIGMSVYNVGIMCII	GABBR2	691	O75899
MRAIMSTALGYCYTF	SLC22A8	206	Q8TCC7
GMLFCYDVSMYQSKD	FOCAD	836	Q5VW36
CFLMMTIAYTKLYCN	LGR5	736	O75473
RYMIMKNPEVEFCGY	POLR1D	56	P0DPB6
EMSYMYDFCTLISIK	TMEM106B	206	Q9NUM4
MAVYCYALNSLVIMN	ITPKB	1	P27987
KVISYFGCMTQMFFY	OR5AU1	141	Q8NGC0
NCLMYKMCYYRFGQV	STT3A	636	P46977
AISYMDCLTQVYFSM	OR7D2	91	Q96RA2
GFEENKCSMSYMFEY	PGAP1	31	Q75T13
FSYKEMLIGYMLDFI	MROH2B	776	Q7Z745
YILAVMAFDRYMAGC	OR5M9	111	Q8NGP3
YDLMTMAFKYQVLLC	OSCP1	101	Q8WVF1
CDAYLQMKGNREMVY	SUPT4H1	36	P63272
LMAYVAENSVLFMCY	SLC25A2	71	Q9BXI2
VSMTYGSCIFMYIKP	OR6C6	246	A6NF89
FIGCLNVKATMYEMY	CIDEA	141	O60543
CMDSTVKYMNFYKIP	CNGB1	896	Q14028
TVYYVSLSMGCVMFE	TMEM244	26	Q5VVB8
SKLSNKIGMNCDYYM	TCP11	56	Q8WWU5
SMMISAEYPKVCQYL	TRIM77	176	I1YAP6
VYTFTERMMAYCDQI	ST6GALNAC4	181	Q9H4F1
NMGYSYECVLRAMKK	UBAP1	401	Q9NZ09
MCIYKYGSMSMSFEA	SPO11	286	Q9Y5K1
YYCRLYAMQTGMKID	VTA1	36	Q9NP79
GECVMKMFALRQYYF	SCN10A	1521	Q9Y5Y9
LGFEEFCAFYKMMST	PLCH2	226	O75038
YLEYFLMAVINGCQM	PSTK	86	Q8IV42
KLVMVLFQYCIMANY	SCTR	216	P47872
AMYYCAMGARSSEKE	VPREB1	111	P12018
AMFIKYWIYVCGGMF	PIEZO2	681	Q9H5I5
MYKIIYMVLFLFCVA	PIEZO2	706	Q9H5I5
MYLEVKNSQYSCSEM	ZDBF2	1146	Q9HCK1
IVDCLTEMYYMGTAI	USP9Y	1521	O00507
LCKGSAFLMYMNFYS	GPR65	86	Q8IYL9
YFRQGMIIYDKMSIF	ZNF420	106	Q8TAQ5
MSKIGYFYTDCLVPM	PSMG2	41	Q969U7
EYSVFLTMLCMAYND	S100A5	71	P33763
MTCILYVVVSGNLMY	SLC32A1	216	Q9H598
MESEKIYMTANPYLC	ZNF883	1	P0CG24
QKMFTYLMESECKAY	USP34	1941	Q70CQ2
KMFLRGTFYQGYMCT	VAV2	541	P52735
YAFGMCMLEMATSEY	WNK1	406	Q9H4A3
YTEIMKSNGFLDYCM	THSD7B	1496	Q9C0I4
YLCYTMKVFTKMCDI	TUT7	1146	Q5VYS8
MGFPMDACRKAVYYT	USP5	666	P45974
ECMSKYTVLFYQMAK	ZMYM4	801	Q5VZL5
LCRAVKYLQMVGMYA	AVPR2	111	P30518
NAYTYMMGACVIVFR	NALCN	1296	Q8IZF0
AVGKPMCLLFEYMAY	MUSK	646	O15146